All Stories

  1. Dietary Approaches to Obstructive Sleep Apnea: Translating Mechanistic Pathways into Clinical Practice
  2. The Role of the Renin–Angiotensin–Aldosterone System in Hypertensive Emergencies
  3. Metalloproteinases 2 and 9 as Biomarkers in Acute Elevation of Blood Pressure
  4. Comparison of Oscillometric Blood Pressure Measurements on the Arm and Forearm in Patients with Obesity, Prediabetes, and Hypertension
  5. New Insights on the ideal blood pressure levels for renal protection
  6. Correlations Between Coffee Intake, Glycemic Control, Cardiovascular Risk, and Sleep in Type 2 Diabetes and Hypertension: A 12-Month Observational Study
  7. A new approach to interpreting the LF/HF ratio: a study in hypertensive patients
  8. Electrocardiographic Left Ventricular Mass Trajectories and the Effects of Treatment in Patients at Different Stages of Hypertension
  9. Increased arterial stiffness in normotensive individuals with hypoparathyroidism
  10. The correlation between age, blood pressure variability and estimated pulse wave velocity
  11. The effect of breakfast skipping and sleep disorders on glycemic control, cardiovascular risk, and weight loss in type 2 diabetes
  12. A COVID-19 E A PRESSÃO NO AMBIENTE DE TRABALHO ENFRENTADA POR PROFISSIONAIS DE SAÚDE NO CONTEXTO HOSPITALAR
  13. The Possible Impact of COVID-19 on Glycated Hemoglobin and Systolic Blood Pressure in Type 2 Diabetes and Obesity
  14. Demystifying Obesity: Understanding, Prevention, Treatment, and Stigmas
  15. Nutritional management, skipping breakfast, glycemic control, and cardiovascular risk on type 2 diabetes mellitus
  16. The Impact of a Nutritional Intervention on Glycemic Control and Cardiovascular Risk Markers in Type 2 Diabetes
  17. AGE AND BLOOD PRESSURE DEPENDENCY OF THREE DIFFERENT METHODS TO MEASURE PULSE WAVE VELOCITY
  18. EFFECT OF SEQUENTIAL NEPHRON BLOCKADE X DUAL RENIN-ANGIOTENSIN SYSTEM BLOCKADE + BISOPROLOL IN THE TREATMENT OF RESISTANT HYPERTENSION, A RANDOMIZED CONTROLLED TRIAL (RESHYPOT)
  19. Correlation between estimated pulse wave velocity values from two equations in healthy and under cardiovascular risk populations
  20. Effects of Mindful Eating in Patients with Obesity and Binge Eating Disorder
  21. Diretrizes Brasileiras de Medidas da Pressão Arterial Dentro e Fora do Consultório – 2023
  22. Brazilian Guidelines for In-office and Out-of-office Blood Pressure Measurement – 2023
  23. Nutritional Strategies for the Management of Type 2 Diabetes Mellitus: A Narrative Review
  24. Evaluation of Central Hemodynamics in the Diagnosis and Treatment of Hypertension
  25. Diretrizes Brasileiras de Medidas da Pressão Arterial Dentro e Fora do Consultório – 2023
  26. Abstract P378: Expression Of Micro-rna 221, 222 And 223 In Individuals Suffering From Ischemic Stroke Due To Hypertensive Emergency
  27. EXPRESSION OF MICRO-RNA 221 AND 223 IN ISCHEMIC STROKE DUE HYPERTENSIVE EMERGENCY
  28. ARTERIAL STIFFNESS IN NORMOTENSIVE PATIENTS WITH HYPOPARATHYROIDISM COMPARED TO CONTROLS
  29. SEQUENTIAL NEPHRON BLOCKADE VERSUS DUAL RENIN-ANGIOTENSIN SYSTEM BLOCKADE IN TRUE RESISTANT HYPERTENSIVE PATIENTS: A SYSTEMATIC REVIEW
  30. EVALUATION OF DEPENDENCE OF AGE AND PERIPHERAL BLOOD PRESSURE IN TWO PULSE WAVE VELOCITY ESTIMATION METHODS
  31. The Effect of Transcutaneous Electrical Nerve Stimulation in Peripheral and Central Hemodynamic Parameters on Resistant Hypertension: A Case Report
  32. The Role of Heart Rate Variability (HRV) in Different Hypertensive Syndromes
  33. Effect of Sequential Nephron Blockade versus Dual Renin-Angiotensin System Blockade Plus Bisoprolol in the Treatment of Resistant Hypertension, a Randomized Controlled Trial (Resistant Hypertension on Treatment - ResHypOT)
  34. Editorial: The importance of the central hemodynamic in the cardiovascular diseases development
  35. Inflammatory cytokines are associated to lower glomerular filtration rate in patients with hypertensive crisis
  36. Linear and non-linear analyses of autonomic modulation in uncontrolled and controlled elderly resistant hypertensives
  37. Alterations in pro- and anti-inflammatory mediators are involved in microvascular dysfunction in postmenopausal women with type 2 diabetes mellitus
  38. Smoking and Endothelial Dysfunction: An Integrated - Medical and Molecular Review
  39. CRISES HIPERTENSIVAS: MITOS, VERDADES E CONDUTAS
  40. HIPERTENSÃO E DIABETES: CONCEITOS ATUAIS NA TERAPÊUTICA
  41. Abstract P147: Association Between Lipid Transfer To HDL-c And Arterial Stiffness In Patients With Ischemic Stroke Due To Hypertensive Emergency
  42. Predictive Factors for Target Organ Injuries in Hypertensive Individuals
  43. RELATIONSHIP BETWEEN 24-HOURS URINARY SODIUM EXCRETION AND ARTERIAL STIFFNESS IN CONTROLLED HYPERTENSIVE AND RESISTANT HYPERTENSIVE INDIVIDUALS
  44. Diretrizes Brasileiras de Hipertensão Arterial – 2020
  45. Correction to: Effectiveness of chlorthalidone/amiloride versus losartan in patients with stage I hypertension and diabetes mellitus: results from the PREVER-treatment randomized controlled trial
  46. Evidence of Nonadherence in Cases of Pseudoresistant Hypertension
  47. Implications for Clinical Practice from a Multicenter Survey of Heart Failure Management Centers
  48. QUAL O PAPEL DO BLOQUEIO SEQUENCIAL DO NÉFRON NA HIPERTENSÃO RESISTENTE?
  49. Avaliação do Seguimento de 1 Ano dos Pacientes Incluídos no Registro da Prática Clínica em Pacientes de Alto Risco Cardiovascular (REACT)
  50. Effectiveness of chlorthalidone/amiloride versus losartan in patients with stage I hypertension and diabetes mellitus: results from the PREVER-treatment randomized controlled trial
  51. Randomized Study Comparing Vildagliptin vs Glibenclamide on Glucose Variability and Endothelial Function in Patients with Type 2 Diabetes Mellitus and Hypertension
  52. Abstract P081: Expression Of Micro-rnas And Transfer Of Lipids To HDL In Vitro In Stroke Due To Hypertensive Emergency
  53. May Measurement Month 2018: an analysis of blood pressure screening results from Brazil
  54. Posicionamento Luso-Brasileiro de Emergências Hipertensivas – 2020
  55. Plasma levels of matrix metalloproteinase-9 are elevated in individuals with hypertensive crisis
  56. Posicionamento Brasileiro sobre Hipertensão Arterial Resistente – 2020
  57. Effect of a Multifaceted Quality Improvement Intervention on the Prescription of Evidence-Based Treatment in Patients at High Cardiovascular Risk in Brazil
  58. Central Hemodynamic Parameters are Altered in Resistant Hypertensive Individuals
  59. CRISES HIPERTENSIVAS: DEFININDO A GRAVIDADE E O TRATAMENTO
  60. Effect of vildagliptin versus glibenclamide on endothelial function and arterial stiffness in patients with type 2 diabetes and hypertension: a randomized controlled trial
  61. CIRCULATING LEVELS OF MATRIX METALLOPROTEINASE-9 ARE ELEVATED IN INDIVIDUALS WITH HYPERTENSIVE CRISIS
  62. INFLUENCE OF ANTIHYPERTENSIVE TREATMENT ON MMP-9 LEVELS IN CONTROLLED HYPERTENSIVE INDIVIDUALS
  63. Effectiveness of low-dose diuretics for blood pressure reduction to optimal values in prehypertension
  64. Controlled Versus Uncontrolled Resistant Hypertension: Are They in the Same Bag?
  65. Resistant Hypertension On Treatment (ResHypOT): sequential nephron blockade compared to dual blockade of the renin-angiotensin-aldosterone system plus bisoprolol in the treatment of resistant arterial hypertension – study protocol for a randomized cont...
  66. Prevalence of Physical Inactivity and its Effects on Blood Pressure and Metabolic Parameters in a Brazilian Urban Population
  67. Do thiazide diuretics reduce central systolic blood pressure in hypertension?
  68. Guidelines on the management of arterial hypertension and related comorbidities in Latin America
  69. Effects of acute blood pressure elevation on biochemical-metabolic parameters in individuals with hypertensive crisis
  70. Vascular Peripheric Differences In Patients With Chagas Versus Ischemic Heart Failure
  71. I Luso-Brazilian Positioning on Central Arterial Pressure
  72. Effectiveness of Chlorthalidone Plus Amiloride for the Prevention of Hypertension: The PREVER‐Prevention Randomized Clinical Trial
  73. Angiotensin-Converting Enzyme Inhibitor Use and Major Cardiovascular Outcomes in Type 2 Diabetes Mellitus Treated With the Dipeptidyl Peptidase 4 Inhibitor Alogliptin
  74. [PP.21.02] INDIVIDUALS WITH HYPERTENSIVE EMERGENCY PRESENT ASSOCIATION BETWEEN RENAL DYSFUNCTION AND INFLAMMATORY CYTOKINES
  75. [PP.36.12] METABOLIC CHANGES, BIOMARKERS OF ENDOTHELIAL DYSFUNCTION AND COAGULATION FACTORS ARE PRESENT IN INDIVIDUALS WITH HYPERTENSIVE CRISIS
  76. Endothelial Changes in Individuals with Prehypertension
  77. How to Investigate the Vascular Changes in Resistant Hypertension
  78. Spotlight on valsartan–sacubitril fixed-dose combination for heart failure: the evidence to date
  79. Effectiveness of chlorthalidone/amiloride versus losartan in patients with stage I hypertension
  80. Effects of transcutaneous electrical nerve stimulation (TENS) on arterial stiffness and blood pressure in resistant hypertensive individuals: study protocol for a randomized controlled trial
  81. Chlorthalidone Plus Amiloride Reduces the Central Systolic Blood Pressure in Stage 1 Hypertension Patients
  82. Angiotensin-converting enzyme insertion/deletion polymorphism, 24-h blood pressure profile and left ventricular hypertrophy in hypertensive individuals: a cross-sectional study
  83. Twelve-week randomized study to compare the effect of vildagliptin vs. glibenclamide both added-on to metformin on endothelium function in patients with type 2 diabetes and hypertension
  84. DPP-4 Inhibitor Reduces Central Blood Pressure in a Diabetic and Hypertensive Patient
  85. PP.28.15
  86. PP.20.30
  87. Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trial
  88. Effect of transcutaneous electrical nerve stimulation on peripheral to central blood pressure ratio in healthy subjects
  89. Blockade of Renin Angiotensin System in Heart Failure Post-Myocardial Infarction: What is the Best Therapy?
  90. Prevalence of Metabolic Syndrome: Association with Risk Factors and Cardiovascular Complications in an Urban Population
  91. Is There an Association between Periodontitis and Hypertension?
  92. Nebivolol reduces central blood pressure in stage I hypertensive patients: experimental single cohort study
  93. Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes
  94. Renin Angiotensin System Blockage Associates with Insertion/Deletion Polymorphism of Angiotensin-Converting Enzyme in Patients with Hypertensive Emergency
  95. Evidence-Based Therapy Prescription in High-Cardiovascular Risk Patients: The REACT Study
  96. Carotid intima-media thickness is associated with cognitive deficiency in hypertensive patients with elevated central systolic blood pressure
  97. I posicionamento brasileiro sobre hipertensão arterial resistente
  98. Urinary albumin excretion regression in hypertensive individuals
  99. Hyperglycemia in patients with hypertensive crisis: Response to “Hypertensive crisis: Comparison between diabetics and non-diabetics”
  100. Fatores associados ao aumento no índice de incremento de pressão radial em indivíduos hipertensos
  101. Gene Variation in Resistant Hypertension: Multilocus Analysis of the Angiotensin 1-Converting Enzyme, Angiotensinogen, and Endothelial Nitric Oxide Synthase Genes
  102. Non-dipping pattern relates to endothelial dysfunction in patients with uncontrolled resistant hypertension
  103. Is There An Association Between Vitamin D and Hypertension?
  104. Prevention of hypertension in patients with pre-hypertension: protocol for the PREVER-prevention trial
  105. A comparison between diuretics and angiotensin-receptor blocker agents in patients with stage I hypertension (PREVER-treatment trial): study protocol for a randomized double-blind controlled trial
  106. Hypertensive crisis: clinical–epidemiological profile
  107. Factors associated with impaired urinary albumin excretion in hypertensive individuals
  108. Characteristics of resistant hypertension: ageing, body mass index, hyperaldosteronism, cardiac hypertrophy and vascular stiffness
  109. Metabolic Abnormalities Are Associated with Blood Pressure Control.
  110. UNCONTROLLED AND CONTROLLED RESISTANT HYPERTENSION: REALLY ONLY ONE HYPERTENSIVE CONDITION?: PP.34.412
  111. Prevalência e fatores de risco para hipertensão em uma população urbana brasileira
  112. ARTERIAL AND VENOUS ENDOTHELIAL DYSFUNCTION IN RESISTANT HYPERTENSIVE PATIENTS
  113. Coronary emergency and diabetes as manifestations of pheochromocytoma
  114. Ausência de descenso noturno se associa a acidente vascular cerebral e infarto do miocárdio
  115. Evaluation of the awareness, control and cost-effectiveness of hypertension treatment in a Brazilian city: populational study
  116. H 027 Multifactorial Evaluation of the Interaction of Polymorphisms of Raas Genes and Nitric Oxide Endothelial Synthase in Resistant and Controlled Hypertensive Patients
  117. H 025 Concentric left Ventricular Hypertrophy as an Early Marker of Cardiovascular Risk in Resistant Hypertension
  118. H 005 Hypertensive Crisis: Clinical and Epidemiological Profile
  119. H 004 Nondipper is Associated with Stroke and Myocardial Infarction
  120. H 008 Predictors of In-hospital Mortality in Patients Admitted to Hospital Emergency Presenting Hypertensive Crisis
  121. H 015 Simultaneous Evaluation of Endothelial Function and Velocity of Wave Pulse in Resistant Hypertensive Patients
  122. Factors associated to patients' noncompliance with hypertension treatment
  123. Dissecção aguda de aorta como apresentação de emergência hipertensiva
  124. Prevalência e fatores sociodemográficos em hipertensos de São José do Rio Preto - SP
  125. Disfunção cognitiva após cirurgia cardíaca
  126. H 023 α-ADDUCIN GENETIC VARIANTS AND RISK FACTORS IN SYSTEMIC HYPERTENSION
  127. H 031 THE PREVALENCE OF METABOLIC SYNDROME IN PATIENTS SUFFERING FROM HYPERTENSIVE CRISES
  128. H 024 POLYMORPHISMS OF THE ACE INSERTION/DELETION, M235T ANGIOTENSINOGEN AND ENOS GLU298ASP GENES IN REFRACTORY HYPERTENSION
  129. H 025 EVALUATION OF ENDOTHELIAL FUNCTION AND VASCULAR THICKNESS IN REFRACTORY HYPERTENSIVE PATIENTS
  130. H 026 CARDIOVASCULAR REMODELING (CONCENTRIC LEFT VENTRICLE HYPERTROPHY AND INCREASE IN THE INTIMA-MEDIA THICKNESS) IN REFRACTORY HYPERTENSION
  131. H 029 ACE GENETIC POLYMORPHISMS IN PATIENTS SUFFERING HYPERTENSIVE CRISES
  132. H 036 CARDIOVASCULAR RISK STRATIFICATION IN PATIENTS WITH REFRACTORY ARTERIAL HYPERTENSION
  133. Alike the metabolic syndrome, hypertension is more than just increased blood pressure
  134. Infarto agudo do miocárdio e dissecção aguda de aorta: um importante diagnóstico diferencial
  135. Perfil de crise hipertensiva: prevalência e apresentação clínica
  136. Adenoma de Conn: uma causa de hipertensão e hipocalemia
  137. Introduction and basic concepts